Literature DB >> 26584529

Outbreak of isoniazid-resistant tuberculosis in an immigrant community in Spain.

Cristina Hernán García1, Lourdes Moreno Cea2, Virginia Fernández Espinilla2, Gema Ruiz Lopez Del Prado2, Socorro Fernández Arribas3, Irene Andrés García2, Verónica Rubio2, Silvan Vesenbeckh4, José María Eiros Bouza5.   

Abstract

BACKGROUND: Tuberculosis (TB) remains a major public health problem. In 2013, 9 million new cases of active TB were estimated globally and the proportion of reported new cases with multi-drug resistance (MDR) was 3.5%.
METHODS: Contact tracing of a case of pulmonary tuberculosis was performed in a Bolivian patient. Diagnostic tests were performed according to national and local protocols.
RESULTS: An outbreak of tuberculosis in an immigrant community was detected, with 5 cases originating from one index case. Genotyping and drug susceptibility testing of the sputum samples determined Mycobacterium tuberculosis resistant to isoniazid (KatG-msp unmutated/inhA 5RBS CT). Active case finding revealed a total of 39 contacts with an incidence of latent infection of 71.43%.
CONCLUSIONS: The present study confirms the importance of active case finding through contact tracing as well as rapid laboratory diagnosis to achieve improvements in early detection of TB. Early diagnosis of the patient, compliance with appropriate treatment protocols and monitoring of drug resistance are considered essential for the prevention and control of TB.
Copyright © 2015 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Brote; Contact tracing; Drug-resistant tuberculosis; Estudio de contactos; Immigration; Infección tuberculosa latente; Inmigración; Latent tuberculosis; Outbreak; Tuberculosis resistente

Mesh:

Substances:

Year:  2015        PMID: 26584529     DOI: 10.1016/j.arbres.2015.07.014

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  1 in total

1.  Caregiver willingness to give TPT to children living with drug-resistant TB patients.

Authors:  V Rouzier; M Murrill; S Kim; L Naini; J Shenje; E Mitchell; M Raesi; M Lourens; A Mendoza; F Conradie; N Suryavanshi; M Hughes; S Shah; G Churchyard; S Swindells; A Hesseling; A Gupta
Journal:  Int J Tuberc Lung Dis       Date:  2022-10-01       Impact factor: 3.427

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.